These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39024058)

  • 1. Carnosic Acid: A Novel Selective Inhibitor of ERAP1 by Direct Binding and Its Modulation of Antigen Processing and Presentation.
    Wu J; Li Z; Liu X; Feng D; Liang R; Su X; Li D; Hua H; Cao H
    J Agric Food Chem; 2024 Aug; 72(31):17343-17355. PubMed ID: 39024058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen Presentation.
    Liddle J; Hutchinson JP; Kitchen S; Rowland P; Neu M; Cecconie T; Holmes DS; Jones E; Korczynska J; Koumantou D; Lea JD; Nickels L; Pemberton M; Phillipou A; Schneck JL; Sheehan H; Tinworth CP; Uings I; Wojno-Picon J; Young RJ; Stratikos E
    J Med Chem; 2020 Mar; 63(6):3348-3358. PubMed ID: 32109056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.
    Li L; Batliwala M; Bouvier M
    J Biol Chem; 2019 Dec; 294(49):18534-18544. PubMed ID: 31601650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate effects of the ankylosing spondylitis associated ERAP1 and ERAP2 aminopeptidases determine the influence of their combined phenotype on the HLA-B*27 peptidome.
    Martín-Esteban A; Sanz-Bravo A; Guasp P; Barnea E; Admon A; López de Castro JA
    J Autoimmun; 2017 May; 79():28-38. PubMed ID: 28063628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of ankylosing spondylitis-associated ERAP1 polymorphisms outside the catalytic and peptide-binding sites on the processing of natural HLA-B27 ligands.
    Martín-Esteban A; Gómez-Molina P; Sanz-Bravo A; López de Castro JA
    J Biol Chem; 2014 Feb; 289(7):3978-90. PubMed ID: 24352655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
    Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
    Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common allotypes of ER aminopeptidase 1 have substrate-dependent and highly variable enzymatic properties.
    Hutchinson JP; Temponeras I; Kuiper J; Cortes A; Korczynska J; Kitchen S; Stratikos E
    J Biol Chem; 2021; 296():100443. PubMed ID: 33617882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERAP1-Dependent Antigen Cross-Presentation Determines Efficacy of Adoptive T-cell Therapy in Mice.
    Schmidt K; Keller C; Kühl AA; Textor A; Seifert U; Blankenstein T; Willimsky G; Kloetzel PM
    Cancer Res; 2018 Jun; 78(12):3243-3254. PubMed ID: 29559473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function.
    D'Amico S; D'Alicandro V; Compagnone M; Tempora P; Guida G; Romania P; Lucarini V; Melaiu O; Falco M; Algeri M; Pende D; Cifaldi L; Fruci D
    Front Immunol; 2021; 12():778103. PubMed ID: 34917091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERAP1 in ankylosing spondylitis: genetics, biology and pathogenetic role.
    Alvarez-Navarro C; López de Castro JA
    Curr Opin Rheumatol; 2013 Jul; 25(4):419-25. PubMed ID: 23656713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERAP1 Controls the Autoimmune Response against Melanocytes in Psoriasis by Generating the Melanocyte Autoantigen and Regulating Its Amount for HLA-C*06:02 Presentation.
    Arakawa A; Reeves E; Vollmer S; Arakawa Y; He M; Galinski A; Stöhr J; Dornmair K; James E; Prinz JC
    J Immunol; 2021 Nov; 207(9):2235-2244. PubMed ID: 34580106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ERAP1 and ERAP2 gene polymorphisms on disease susceptibility in different populations.
    Yao Y; Liu N; Zhou Z; Shi L
    Hum Immunol; 2019 May; 80(5):325-334. PubMed ID: 30797823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses.
    Zervoudi E; Saridakis E; Birtley JR; Seregin SS; Reeves E; Kokkala P; Aldhamen YA; Amalfitano A; Mavridis IM; James E; Georgiadis D; Stratikos E
    Proc Natl Acad Sci U S A; 2013 Dec; 110(49):19890-5. PubMed ID: 24248368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1.
    Mavridis G; Arya R; Domnick A; Zoidakis J; Makridakis M; Vlahou A; Mpakali A; Lelis A; Georgiadis D; Tampé R; Papakyriakou A; Stern LJ; Stratikos E
    J Biol Chem; 2020 May; 295(21):7193-7210. PubMed ID: 32184355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERAP1 and ankylosing spondylitis.
    Keidel S; Chen L; Pointon J; Wordsworth P
    Curr Opin Immunol; 2013 Feb; 25(1):97-102. PubMed ID: 23452840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERAP1 in the pathogenesis of ankylosing spondylitis.
    Reeves E; Elliott T; James E; Edwards CJ
    Immunol Res; 2014 Dec; 60(2-3):257-69. PubMed ID: 25434650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding new light on the role of ERAP1 in Type 1 diabetes: A perspective on disease management.
    Paldino G; Fierabracci A
    Autoimmun Rev; 2023 Apr; 22(4):103291. PubMed ID: 36740089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.
    Chen L; Ridley A; Hammitzsch A; Al-Mossawi MH; Bunting H; Georgiadis D; Chan A; Kollnberger S; Bowness P
    Ann Rheum Dis; 2016 May; 75(5):916-23. PubMed ID: 26130142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERAP1: a potential therapeutic target for a myriad of diseases.
    Reeves E; Islam Y; James E
    Expert Opin Ther Targets; 2020 Jun; 24(6):535-544. PubMed ID: 32249641
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of ERAP1 in autoinflammation and autoimmunity.
    Pepelyayeva Y; Amalfitano A
    Hum Immunol; 2019 May; 80(5):302-309. PubMed ID: 30817945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.